GFAP and Alzheimer disease: While PET radio-ligands provide regional specificity, integrating fluid-based biomarkers—such as CSF cytokines or plasma GFAP—with neuroimaging endophenotypes offers unprecedented insights into the spatiotemporal interplay between neuroinflammation and AD pathophysiology (Hampel et al., 2020).